Catalyst Wire Dossier Catalyst Wire Dossier

A140

· Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A140, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC [Phase 3]

See pricing